By proceeding, you agree to our Terms of Use and Privacy Policy.
Svar Life Science (formerly Euro Diagnostica AB) is a Swedish life science company that invents, develops and applies the best analytical technologies for drug development and clinical research, and establishes practical platforms for routine diagnos
27-29 September 2022
With promising clinical data, an increasing number of candidates progressing through the clinic and a rise in diseases where complement drugs are being applied, it's time to accelerate transformative complement-targeted approaches towards approval! A
Event Ended
USA
Paid
Boston
03-06 October 2022
CHI is excited to host its 14th Annual Immunogenicity & Bioassay Summit – a “Live” In-Person & Virtual event. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches.
Hybrid
Washington D.C
14-16 November 2022
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe.
Spain
Barcelona
28-01 December 2022
Develop, Validate & Implement Cell-Based & Biophysical Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products at Scale The past twelve months have culminated in an unprecedented level of excitement, investm
18-20 April 2023
The pharmaceutical industry is currently focused on developing biologic drugs that target the FcRn receptor pathway to treat autoimmune diseases, with companies such as Argenx, Janssen, UCB and Immunovant competing to tackle myasthenia gravis. The 3r
15-19 May 2023
The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth prese
11-13 September 2023
The field of complement-based drug development is experiencing growth due to several factors. Firstly, there is an increasing recognition of the role of the complement system in a wider range of diseases. Additionally, there is a better understanding